Genomics at the service of Oncology

A complete study for the detection of genetic predisposition to prostate cancer

About 15% of prostate cancers are hereditary

DNA.files PROSTATE is a service that screens the genetic predisposition to the development of prostate cancer, as well as to adapt the clinical treatment.

Why DNA.files PROSTATE?

Higher prevalence

in Portugal, prostate cancer is the most common cancer in men.

15% has a genetic predisposition

prostate cancer is the one with the highest heritability.

Increase of 58.1%

of new cases of prostate cancer worldwide by 2040.

A genetic study designed to support prostate cancer

Through the DNA.files PROSTATE, it is possible to identify mutations in about 34 genes associated to the development of this pathology and adapt the therapeutic according to the patient’s genetic context.